Diabetes arises when pancreas, the endocrine gland, stop producing sufficient insulin, or when body can't efficiently use the produced insulin. Insulin is a hormone that maintains the blood sugar level by making it to enter the cells where it is used as a fuel. In most of the developed countries, diabetes is the 4th major death cause. Every year, worldwide, above 3 million deaths occur because of diabetes-linked causes.
In the absence of proper insulin production and action, blood retains the sugar that leads to an increased level of glucose in blood (hyperglycemia). As a result, various long and short-term complications may arise, which if not averted and treated, can proved to be fatal.
Drug Delivery Technologies and Markets look at the aim of developing drug delivery technology, including improvement in safety and efficiency, product's life extension and improved compliance. Economics or finance is the major driver of drug delivery technology development. Advantages of new formulations that provide a competitive edge after patent expiry, drug rescue, reduction of healthcare costs, market extension and reduction of cost of drug development are all taken into account, thereby, making it necessary for anyone who is involved in drug delivery segment.
The technologies that are being researched and developed will complete and used commercially in the near future. So, it is possible that the drug delivery products' sales would rise by 100% in next 5 years.
For further information about insulin delivery system, read the report "New Developments in Insulin Delivery Systems (2006)" by RNCOS at:
http://www.rncos.com/Report/COM31.htm
RNCOS is an industry leader in the field of online business research. We specialize in industry research on various business verticals. To read our other reports, visit: http://www.rncos.com/Report.htm or email us at info@rncos.com
To get the latest news on Pharmaceutical Industries worldwide, please visit our newly launched Blog section at http://www.rncos.com/Blog/pharma.html